Ledger.Open graph →
SEC Form D · filed February 7, 2025

Ambagon Therapeutics Inc

Offering
$12.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Eindhoven, P7
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Melissa Mccracken · Eindhoven, P7DirectorJosh Seidenfeld · Palo Alto, CAExecChristian Ottmann · Eindhoven, P7ExecMelissa Mccracken · Eindhoven, P7DirectorJosh Seidenfeld · Palo Alto, CAExecChristian Ottmann · Eindhoven, P7Exec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗